Novast Laboratories, Ltd. NDCs and Package Codes
This page lists NDC package records associated with labeler code 34908 (Novast Laboratories, Ltd.) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.
Key stats
16
Package NDCs
4
Products
4
Active listings
0
Discontinued
1
Ingredients
0
Therapeutic classes
1
Dosage forms
0
With NADAC pricing
Portfolio
Top ingredients
By dosage form
Browse records — 4 products
| Drug / product | Billing NDC | NADAC / unit | Status | |
|---|---|---|---|---|
| Quetiapine Fumarate 200 mg/1 TABLET, EXTENDED RELEASE | 34908-0637-10 | — | On market | View → |
| Quetiapine Fumarate 150 mg/1 TABLET, EXTENDED RELEASE | 34908-0636-10 | — | On market | View → |
| Quetiapine Fumarate 300 mg/1 TABLET, EXTENDED RELEASE | 34908-0638-10 | — | On market | View → |
| Quetiapine Fumarate 400 mg/1 TABLET, EXTENDED RELEASE | 34908-0639-10 | — | On market | View → |
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.